BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16285033)

  • 1. Concurrent radio-chemotherapy combination in patients with advanced head and neck squamous cell carcinoma.
    Bourhis J
    Onkologie; 2005 Oct; 28(10):473-4. PubMed ID: 16285033
    [No Abstract]   [Full Text] [Related]  

  • 2. A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
    Wilkowski R; Pachmann S; Schymura B; Dellian M; Schalhorn A; Dühmke E
    Onkologie; 2005 Oct; 28(10):491-5. PubMed ID: 16160398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rash conclusions from a phase 3 study of cetuximab?
    Harrington KJ
    Lancet Oncol; 2010 Jan; 11(1):2-3. PubMed ID: 20129123
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential chemotherapy and radiotherapy in advanced head and neck cancer.
    Stell PM; Dalby JE; Strickland P; Fraser JG; Bradley PJ; Flood LM
    Clin Radiol; 1983 Jul; 34(4):463-7. PubMed ID: 6409493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.
    Chan AK; Sanghera P; Choo BA; McConkey C; Mehanna H; Parmar S; Pracy P; Glaholm J; Hartley A
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):34-9. PubMed ID: 20863676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of chemotherapy in head and neck cancer.
    Brockstein B
    Lancet; 2000 Aug; 356(9231):767-8. PubMed ID: 11085713
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
    Bonner JA; Harari PM; Giralt J; Cohen RB; Jones CU; Sur RK; Raben D; Baselga J; Spencer SA; Zhu J; Youssoufian H; Rowinsky EK; Ang KK
    Lancet Oncol; 2010 Jan; 11(1):21-8. PubMed ID: 19897418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent radiation chemotherapy for locally advanced head and neck carcinoma: are we addressing burning subjects?
    Ang KK
    J Clin Oncol; 2004 Dec; 22(23):4657-9. PubMed ID: 15534361
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
    Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():172-8. PubMed ID: 16897997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Better tumor control by simultaneous radiochemotherapy in advanced head-neck carcinomas].
    Wendt TG
    Strahlenther Onkol; 1999 Sep; 175(9):473-4. PubMed ID: 10518984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Radio-chemotherapy in head and neck cancer (EGFR+)].
    Ozsahin M; Matzinger O; Zimmermann M; Zouhair A
    Bull Cancer; 2007 Sep; 94(9):828-32. PubMed ID: 17878104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in head and neck cancer.
    Agarwala SS
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):743-52, vii. PubMed ID: 10494510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in chemotherapy for head and neck cancer.
    Bhide SA; Nutting CM
    Oral Oncol; 2010 Jun; 46(6):436-8. PubMed ID: 20400360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
    Cooper JS; Pajak TF; Forastiere AA; Jacobs J; Campbell BH; Saxman SB; Kish JA; Kim HE; Cmelak AJ; Rotman M; Machtay M; Ensley JF; Chao KS; Schultz CJ; Lee N; Fu KK;
    N Engl J Med; 2004 May; 350(19):1937-44. PubMed ID: 15128893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy.
    Jeremić B; Miličić B
    Am J Clin Oncol; 2009 Oct; 32(5):483-7. PubMed ID: 19506455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
    Taguchi T; Tsukuda M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemoradiotherapy of carcinomas of the upper aerodigestive tract].
    Bourhis J; Calais G; Eschwège F
    Cancer Radiother; 1998 Dec; 2(6):679-88. PubMed ID: 9922773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.